MeSH Review:
Bone Neoplasms
- Simultaneous reduction in cancer pain, bone destruction, and tumor growth by selective inhibition of cyclooxygenase-2. Sabino, M.A., Ghilardi, J.R., Jongen, J.L., Keyser, C.P., Luger, N.M., Mach, D.B., Peters, C.M., Rogers, S.D., Schwei, M.J., de Felipe, C., Mantyh, P.W. Cancer Res. (2002)
- Approval summary for zoledronic acid for treatment of multiple myeloma and cancer bone metastases. Ibrahim, A., Scher, N., Williams, G., Sridhara, R., Li, N., Chen, G., Leighton, J., Booth, B., Gobburu, J.V., Rahman, A., Hsieh, Y., Wood, R., Vause, D., Pazdur, R. Clin. Cancer Res. (2003)
- Inhibition of platelet-derived growth factor-mediated proliferation of osteosarcoma cells by the novel tyrosine kinase inhibitor STI571. McGary, E.C., Weber, K., Mills, L., Doucet, M., Lewis, V., Lev, D.C., Fidler, I.J., Bar-Eli, M. Clin. Cancer Res. (2002)
- Changes in plasma bone GLA protein during treatment of bone disease. Deftos, L.J., Parthemore, J.G., Price, P.A. Calcif. Tissue Int. (1982)
- Osteoprotegerin blocks bone cancer-induced skeletal destruction, skeletal pain and pain-related neurochemical reorganization of the spinal cord. Honore, P., Luger, N.M., Sabino, M.A., Schwei, M.J., Rogers, S.D., Mach, D.B., O'keefe, P.F., Ramnaraine, M.L., Clohisy, D.R., Mantyh, P.W. Nat. Med. (2000)
- Bone cancer from radium: canine dose response explains data for mice and humans. Raabe, O.G., Book, S.A., Parks, N.J. Science (1980)
- Primary bone neoplasms in beagle dogs exposed by inhalation to aerosols of plutonium-238 dioxide. Hahn, F.F., Mewhinney, J.A., Merickel, B.S., Guilmette, R.A., Boecker, B.B., McClellan, R.O. J. Natl. Cancer Inst. (1981)
- A blocking antibody to nerve growth factor attenuates skeletal pain induced by prostate tumor cells growing in bone. Halvorson, K.G., Kubota, K., Sevcik, M.A., Lindsay, T.H., Sotillo, J.E., Ghilardi, J.R., Rosol, T.J., Boustany, L., Shelton, D.L., Mantyh, P.W. Cancer Res. (2005)
- Herpes vector-mediated expression of proenkephalin reduces bone cancer pain. Goss, J.R., Harley, C.F., Mata, M., O'Malley, M.E., Goins, W.F., Hu, X., Glorioso, J.C., Fink, D.J. Ann. Neurol. (2002)
- Palliation of pain associated with metastatic bone cancer using samarium-153 lexidronam: a double-blind placebo-controlled clinical trial. Serafini, A.N., Houston, S.J., Resche, I., Quick, D.P., Grund, F.M., Ell, P.J., Bertrand, A., Ahmann, F.R., Orihuela, E., Reid, R.H., Lerski, R.A., Collier, B.D., McKillop, J.H., Purnell, G.L., Pecking, A.P., Thomas, F.D., Harrison, K.A. J. Clin. Oncol. (1998)
- Incidence of plutonium-induced bone cancer in neutered mice. Taylor, G.N., Gardner, P., Mays, C.W., Wrenn, M.E., Charrier, K. Cancer Res. (1981)
- Drug and hormone effects on calcium release from bone. Martin, T.J. Pharmacol. Ther. (1983)
- Anti-hyperalgesic activity of the cox-2 inhibitor lumiracoxib in a model of bone cancer pain in the rat. Fox, A., Medhurst, S., Courade, J.P., Glatt, M., Dawson, J., Urban, L., Bevan, S., Gonzalez, I. Pain (2004)
- Bone cancer pain: the effects of the bisphosphonate alendronate on pain, skeletal remodeling, tumor growth and tumor necrosis. Sevcik, M.A., Luger, N.M., Mach, D.B., Sabino, M.A., Peters, C.M., Ghilardi, J.R., Schwei, M.J., Röhrich, H., De Felipe, C., Kuskowski, M.A., Mantyh, P.W. Pain (2004)
- Trisacryl gelatin microspheres versus polyvinyl alcohol particles in the preoperative embolization of bone neoplasms. Basile, A., Rand, T., Lomoschitz, F., Toma, C., Lupattelli, T., Kettenbach, J., Lammer, J. Cardiovascular and interventional radiology. (2004)
- Osteoclasts direct bystander killing of cancer cells in vitro. Ramnaraine, M., Pan, W., Clohisy, D.R. Bone (2006)
- Endothelin and the tumorigenic component of bone cancer pain. Peters, C.M., Lindsay, T.H., Pomonis, J.D., Luger, N.M., Ghilardi, J.R., Sevcik, M.A., Mantyh, P.W. Neuroscience (2004)
- Re-organization of P2X3 receptor localization on epidermal nerve fibers in a murine model of cancer pain. Gilchrist, L.S., Cain, D.M., Harding-Rose, C., Kov, A.N., Wendelschafer-Crabb, G., Kennedy, W.R., Simone, D.A. Brain Res. (2005)
- Regulation of multiple insulin-like growth factor binding protein genes by 1alpha,25-dihydroxyvitamin D3. Matilainen, M., Malinen, M., Saavalainen, K., Carlberg, C. Nucleic Acids Res. (2005)
- Receptor activator for nuclear factor kappaB ligand and osteoprotegerin: regulators of bone physiology and immune responses/potential therapeutic agents and biochemical markers. Buckley, K.A., Fraser, W.D. Ann. Clin. Biochem. (2002)
- Analysis of polymorphisms of the vitamin D receptor, estrogen receptor, and collagen Ialpha1 genes and their relationship with height in children with bone cancer. Ruza, E., Sotillo, E., Sierrasesúmaga, L., Azcona, C., Patiño-García, A. J. Pediatr. Hematol. Oncol. (2003)
- 153Sm-EDTMP and 186Re-HEDP as bone therapeutic radiopharmaceuticals. Ketring, A.R. International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology. (1987)